Table 2.
Primary Outcome Data.
| Routine discharge | DAMA | Rate of DAMA | P value | NNT | |
|---|---|---|---|---|---|
| Initiated on buprenorphine/naloxone (n = 39) | 38 | 1 | 2.56% | .048 | 9 |
| Not initiated on buprenorphine/naloxone (n = 433) | 373 | 60 | 13.85% |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.